OBJECTIVE: Subsetting of Hoechst 33342 dull (Ho(dull)) hematopoietic stem cells on the basis of rhodamine 123 (Rh) efflux utilizing an improved dual-dye efflux strategy resolves Ho(dull)/Rh(dull) stem cell subsets that differ with regard to their rate of recruitment and progression through the cell cycle upon exposure to cytokines. MATERIALS AND METHODS: Murine bone marrow cells were isolated by negative immunomagnetic selection using lineage-directed antibodies followed by Ho and Rh staining using a dual-dye efflux method. RESULTS: Ho(dull)/Rh(dull) stem cells that efflux Rh more efficiently (R1) exhibit a 4- to 8-hour delay in progression to S phase when stimulated by interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor (SCF) compared to Ho(dull)/Rh(medium) stem cells, which retain low levels of Rh (R2). R1 and R2 cells show a hierarchical entry into S phase upon exposure to any or all of these cytokines. The R1 subset contains proportionately more high proliferative potential colony-forming cells than the R2 subset, but equivalent levels of engraftable stem cells at 3 and 8 weeks after competitive transplantation. Both R1 and R2 cells express c-kit, IL-3R, and IL-11R, whereas IL-6R and c-fms are only expressed by R1 or R2 cells, respectively. Cytokine stimulation of R1 and R2 cells induced cell cycle progression with elevated or induced expression of c-kit, c-fms, IL-2R, and IL-6R. CONCLUSION: These studies indicate that primitive marrow stem cells can be further subsetted by degree of Rh staining to reveal important functional phenotypic differences between cells with different levels of Rh staining.
OBJECTIVE: Subsetting of Hoechst 33342 dull (Ho(dull)) hematopoietic stem cells on the basis of rhodamine 123 (Rh) efflux utilizing an improved dual-dye efflux strategy resolves Ho(dull)/Rh(dull) stem cell subsets that differ with regard to their rate of recruitment and progression through the cell cycle upon exposure to cytokines. MATERIALS AND METHODS:Murine bone marrow cells were isolated by negative immunomagnetic selection using lineage-directed antibodies followed by Ho and Rh staining using a dual-dye efflux method. RESULTS: Ho(dull)/Rh(dull) stem cells that efflux Rh more efficiently (R1) exhibit a 4- to 8-hour delay in progression to S phase when stimulated by interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor (SCF) compared to Ho(dull)/Rh(medium) stem cells, which retain low levels of Rh (R2). R1 and R2 cells show a hierarchical entry into S phase upon exposure to any or all of these cytokines. The R1 subset contains proportionately more high proliferative potential colony-forming cells than the R2 subset, but equivalent levels of engraftable stem cells at 3 and 8 weeks after competitive transplantation. Both R1 and R2 cells express c-kit, IL-3R, and IL-11R, whereas IL-6R and c-fms are only expressed by R1 or R2 cells, respectively. Cytokine stimulation of R1 and R2 cells induced cell cycle progression with elevated or induced expression of c-kit, c-fms, IL-2R, and IL-6R. CONCLUSION: These studies indicate that primitive marrow stem cells can be further subsetted by degree of Rh staining to reveal important functional phenotypic differences between cells with different levels of Rh staining.
Authors: Jason M Aliotta; David Lee; Napoleon Puente; Sam Faradyan; Edmund H Sears; Ashley Amaral; Laura Goldberg; Mark S Dooner; Mandy Pereira; Peter J Quesenberry Journal: Stem Cells Dev Date: 2012-02-15 Impact factor: 3.272
Authors: L R Goldberg; M S Dooner; K W Johnson; E F Papa; M G Pereira; M Del Tatto; D M Adler; J M Aliotta; P J Quesenberry Journal: Leukemia Date: 2013-08-30 Impact factor: 11.528
Authors: Peter J Quesenberry; Gerri J Dooner; Michael Del Tatto; Gerald A Colvin; Kevin Johnson; Mark S Dooner Journal: Stem Cells Dev Date: 2010-04 Impact factor: 3.272
Authors: Peter J Quesenberry; Mark S Dooner; Laura R Goldberg; Jason M Aliotta; Mandy Pereira; Ashley Amaral; Michael M Del Tatto; Douglas C Hixson; Bharat Ramratnam Journal: Trans Am Clin Climatol Assoc Date: 2012
Authors: Liansheng Liu; Elaine F Papa; Mark S Dooner; Jason T Machan; Kevin W Johnson; Laura R Goldberg; Peter J Quesenberry; Gerald A Colvin Journal: PLoS One Date: 2012-02-09 Impact factor: 3.240
Authors: Jean-Francois Lambert; Meng Liu; Gerald A Colvin; Mark Dooner; Christina I McAuliffe; Pamela S Becker; Bernard G Forget; Sherman M Weissman; Peter J Quesenberry Journal: J Exp Med Date: 2003-06-02 Impact factor: 14.307